MedTrace Logo

Child-Parent Psychotherapy - a Feasibility Study for Children in Foster Care

NCT04519229 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-10-10

No results posted yet for this study

Summary

Children in foster care have an increased risk of exposure to adverse experiences during childhood and across the lifespan. In current studies of interventions children in foster care are often excluded, or they are too few to be included in statistical analyses of outcomes. As a consequence, knowledge on feasibility of treatment methods for some of the most exposed and maltreated children in society is sparse.

Child-Parent Psychotherapy (CPP) is an intervention for children 0-6 years who have been exposed to adverse and traumatic events. CPP is currently being implemented in Sweden. The aim of this study is to investigate the feasibility of CPP for children in foster care.

Conditions

  • Child Abuse
  • Child Neglect
  • Post-Traumatic Stress Disorder in Children
  • Parent-Child Relations

Interventions

BEHAVIORAL

Child-Parent Psychotherapy

Relationship-based trauma focused psychotherapy for Children 0-6 years old and their caregivers. The objective is to decrease symptoms of post-traumatic tress and re-establish a secure attachment for the child and good caregiving from the caregiver/s.

Sponsors & Collaborators

  • Stiftelsen Allmänna Barnhuset

    collaborator UNKNOWN

  • Kronoberg County Council

    lead OTHER_GOV

Principal Investigators

  • Karin Pernebo, PhD · Department of Psychology, Linnaeus University, Sweden and Department of Research and Development, Region Kronoberg, Sweden

Eligibility

Min Age
0 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-30
Primary Completion
2025-06-30
Completion
2025-12-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04519229 on ClinicalTrials.gov